Latest Market Strategy News

Saferoads Holdings Limited reported a modest rise in quarterly sales and a half-year net profit of approximately $511k, while progressing regulatory approval for its innovative HV2 barrier.

Liontown Limited has successfully transitioned to fully underground lithium mining at Kathleen Valley, boosting production and revenue while cutting costs. The company also secured a significant new offtake agreement and validated strong market demand through its inaugural spodumene auction.

Betr Entertainment Limited reported a robust 25% headline turnover growth in Q2 FY26 despite a $13.2 million EBITDA loss in H1 due to customer-friendly racing outcomes and strategic investments. The company targets a positive EBITDA turnaround in H2 FY26 and FY27, supported by organic growth, Sky Racing integration, and a new share buyback program.

PainChek has secured FDA-regulated medical device status, enabling US Remote Therapeutic Monitoring reimbursement and opening a major US growth avenue. The company targets musculoskeletal pain management in non-verbal dementia patients, a largely underserved market.

Lotus Resources has made significant progress resolving sulphuric acid supply issues critical to ramping up production at its Kayelekera Uranium Mine, though full steady-state output is now expected in the second quarter of 2026.

Canadian Phosphate Limited has improved its operating cash flow and strengthened its balance sheet through a successful capital raise and asset sale, while advancing key permits and strategic partnerships for its Canadian phosphate projects.

Excite Technology Services has reported a record-breaking quarter with $9.2 million in customer receipts, marking a 125% increase year-over-year, alongside positive operating cash flow and strategic contract wins.

Lynas Rare Earths reported a 43% year-on-year revenue increase to A$201.9 million in Q2 FY26 despite a 30% drop in key NdPr production due to power disruptions and maintenance. The company also announced CEO Amanda Lacaze’s planned retirement at year-end.

SportsHero Limited has reported its highest quarterly cash receipts since listing, driven by a milestone payment from its Philippines launch and rapid subscriber growth for its HeroPlay platform in Indonesia.

Ion Video Limited has completed significant restructuring, strengthened its Melbourne-based tech team, and raised $2.95 million, positioning itself for a technology relaunch in February 2026 with a cash runway extending to mid-2027.

Arovella Therapeutics has taken a significant step forward by submitting an IND application to the U.S. FDA for its lead CAR-iNKT cell therapy, ALA-101, targeting blood cancers. This milestone paves the way for a first-in-human Phase 1 trial in both Australia and the U.S.

Nutritional Growth Solutions announces the departure of CEO Stephen J. Turner, appointing Non-Executive Director Andrew Grover as interim CEO to steer the company through its next phase.